Downregulation of serine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells

Oncogene

Volumn 33, Issue 11, 2014, Pages 1407-1417

  Kurokawa, K ^a   Akaike, Y ^a   Masuda, K ^a   Kuwano, Y ^a   Nishida, K ^a   Yamagishi, N ^a   Kajita, K ^a   Tanahashi, T ^a   Rokutan, K ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

alternative splicing; apoptosis; G1 arrest; HIPK2; SRSF3 (SRp20)

Indexed keywords

AMINO ACID; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E1; CYCLINE; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; MESSENGER RNA; MESSENGER RNA PRECURSOR; NUCLEOTIDE; PROTEIN P53; RETINOBLASTOMA PROTEIN; SERINE ARGININE RICH PROTEIN; SERINE ARGININE RICH SPLICING FACTOR 3; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F7; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; COLON CANCER; CONTROLLED STUDY; EXON; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; S PHASE CELL CYCLE CHECKPOINT; UPREGULATION; WESTERN BLOTTING;

ALTERNATIVE SPLICING; APOPTOSIS; COLONIC NEOPLASMS; DOWN-REGULATION; G1 PHASE; HUMANS; RNA-BINDING PROTEINS;

EID: 84896395111     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.86     Document Type: Article

References (44)

1. Manley JL, Krainer AR. A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). Genes Dev 2010; 24: 1073-1074.
2. Chen M, Manley JL. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 2009; 10: 741-754.
3. Lin S, Coutinho-Mansfield G, Wang D, Pandit S, Fu X-D. The splicing factor SC35 has an active role in transcriptional elongation. Nat Struct Mol Biol 2008; 15: 819-826.
4. Lou H, Neugebauer KM, Gagel RF, Berget SM. Regulation of alternative poly-adenylation by U1 snRNPs and SRp20. Mol Cell Biol 1998; 18: 4977-4985. (Pubitemid 28388080)
5. Sapra AK, Anko ML, Grishina I, Lorenz M, Pabis M, Poser I et al. SR protein family members display diverse activities in the formation of nascent and mature mRNPs in vivo. Mol Cell 2009; 34: 179-190.
6. Zhang Z, Krainer AR. Involvement of SR proteins in mRNA surveillance. Mol Cell 2004; 16: 597-607. (Pubitemid 39531882)
7. Sanford JR, Gray NK, Beckmann K, Caceres JF. A novel role for shuttling SR proteins in mRNA translation. Genes Dev 2004; 18: 755-768. (Pubitemid 38480888)
8. Anczuków O, Rosenberg AZ, Akerman M, Das S, Zhan L, Karni R et al. The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nat Struct Mol Biol 2012; 19: 220-228.
9. Ghigna C, Moroni M, Porta C, Riva S, Biamonti G. Altered expression of heterogeneous nuclear ribonucleoproteins and SR factors in human colon adenocarci-nomas. Cancer Res 1998; 58: 5818-5824. (Pubitemid 29006424)
10. Ahn E-Y, DeKelver Russell C, Lo M-C, Nguyen Tuyet A, Matsuura S, Boyapati A et al. SON controls cell-cycle progression by coordinated regulation of RNA splicing. Mol Cell 2011; 42: 185-198.
11. Li X, Manley JL. Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability. Cell 2005; 122: 365-378. (Pubitemid 41127139)
12. Li X, Wang J, Manley JL. Loss of splicing factor ASF/SF2 induces G2 cell cycle arrest and apoptosis, but inhibits internucleosomal DNA fragmentation. Genes Dev 2005; 19: 2705-2714. (Pubitemid 41627937)
13. Xiao R, Sun Y, Ding J, Lin S, Rose D, Rosenfeld M et al. Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organo-genesis. Mol Cell Biol 2007; 27: 5393-5402. (Pubitemid 47124393)
14. Moore MJ, Wang Q, Kennedy CJ, Silver PA. An alternative splicing network links cell-cycle control to apoptosis. Cell 2010; 142: 625-636.
15. Srebrow A, Kornblihtt A. The connection between splicing and cancer. J Cell Sci 2006; 119: 2635-2641. (Pubitemid 44184000)
16. He X, Ee P, Coon J, Beck W. Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20. Clin Cancer Res 2004; 10: 4652-4660. (Pubitemid 38955515)
17. He X, Arslan AD, Pool MD, Ho TT, Darcy KM, Coon JS et al. Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer. Oncogene 2011; 30: 356-365.
18. Stickeler E, Kittrell F, Medina D, Berget SM. Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 1999; 18: 3574-3582. (Pubitemid 29322382)
19. Jumaa H, Wei G, Nielsen PJ. Blastocyst formation is blocked in mouse embryos lacking the splicing factor SRp20. Curr Biol 1999; 9: 899-902. (Pubitemid 29456007)
20. Änkö ML, Morales L, Henry I, Beyer A, Neugebauer KM. Global analysis reveals SRp20-and SRp75-specific mRNPs in cycling and neural cells. Nat Struct Mol Biol 2010; 17: 962-970.
21. Hailemariam K, Iwasaki K, Huang BW, Sakamoto K, Tsuji Y. Transcriptional regulation of ferritin and antioxidant genes by HIPK2 under genotoxic stress. J Cell Sci 2010; 123: 3863-3871.
22. Hofmann TG, Moller A, Sirma H, Zentgraf H, Taya Y, Droge W et al. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 2002; 4: 1-10. (Pubitemid 34071974)
23. D'Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S et al. Home-odomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 2002; 4: 11-19.
24. Wei G, Ku S, Ma GK, Saito S, Tang AA, Zhang J et al. HIPK2 represses b-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis. Proc Natl Acad Sci USA 2007; 104: 13040-13045. (Pubitemid 351737589)
25. Winter M, Sombroek D, Dauth I, Moehlenbrink J, Scheuermann K, Crone J et al. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. Nat Cell Biol 2008; 10: 812-824. (Pubitemid 351927710)
26. Rinaldo C, Prodosmo A, Mancini F, Iacovelli S, Sacchi A, Moretti F et al. MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Mol Cell 2007; 25: 739-750. (Pubitemid 46341925)
27. Choi DW, Seo YM, Kim EA, Sung KS, Ahn JW, Park SJ et al. Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1. J Biol Chem 2008; 283: 4682-4689.
28. Calzado MA, de la Vega L, Moller A, Bowtell DD, Schmitz ML. An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response. Nat Cell Biol 2009; 11: 85-91.
29. Kim SY, Choi DW, Kim EA, Choi CY. Stabilization of HIPK2 by escape from pro-teasomal degradation mediated by the E3 ubiquitin ligase Siah1. Cancer Lett 2009; 279: 177-184.
30. Sombroek D, Hofmann TG. How cells switch HIPK2 on and off. Cell Death Differ 2009; 16: 187-194.
31. Puca R, Nardinocchi L, Givol D, D'Orazi G. Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells. Oncogene 2010; 29: 4378-4387.
32. Zhong XY, Wang P, Han J, Rosenfeld MG, Fu XD. SR proteins in vertical integration of gene expression from transcription to RNA processing to translation. Mol Cell 2009; 35: 1-10.
33. Loomis RJ, Naoe Y, Parker JB, Savic V, Bozovsky MR, Macfarlan T et al. Chromatin binding of SRp20 and ASF/SF2 and dissociation from mitotic chromosomes is modulated by histone H3 serine 10 phosphorylation. Mol Cell 2009; 33: 450-461.
34. Schwerk C, Schulze-Osthoff K. Regulation of apoptosis by alternative pre-mRNA splicing. Mol Cell 2005; 19: 1-13. (Pubitemid 40884653)
35. Kim YH, Choi CY, Lee SJ, Conti MA, Kim Y. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J Biol Chem 1998; 273: 25875-25879. (Pubitemid 28475817)
36. Giraud S, Diaz-Latoud C, Hacot S, Textoris J, Bourette RP, Diaz JJ. US11 of herpes simplex virus type 1 interacts with HIPK2 and antagonizes HIPK2-induced cell growth arrest. J Virol 2004; 78: 2984-2993. (Pubitemid 38314356)
37. Zhang Q, Yoshimatsu Y, Hildebrand J, Frisch SM, Goodman RH. Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the tran-scriptional corepressor CtBP. Cell 2003; 115: 177-186. (Pubitemid 37329581)
38. 2-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res 2003; 63: 8271-8277. (Pubitemid 37549478)
39. Aikawa Y, Nguyen LA, Isono K, Takakura N, Tagata Y, Schmitz ML et al. Roles of HIPK1 and HIPK2 in AML1-and p300-dependent transcription, hematopoiesis and blood vessel formation. EMBO J 2006; 25: 3955-3965. (Pubitemid 44338738)
40. Hikasa H, Ezan J, Itoh K, Li X, Klymkowsky MW, Sokol SY. Regulation of TCF3 by Wnt-dependent phosphorylation during vertebrate axis specification. Dev Cell 2010; 19: 521-532.
41. Lazzari C, Prodosmo A, Siepi F, Rinaldo C, Galli F, Gentileschi M et al. HIPK2 phosphorylates DNp63a and promotes its degradation in response to DNA damage. Oncogene 2011; 30: 4802-4813.
42. D'Orazi G, Rinaldo C, Soddu S. Updates on HIPK2: a resourceful oncosuppressor for clearing cancer. J Exp Clin Cancer Res 2012; 31: 63.
43. Kuwano Y, Kamio Y, Kawai T, Katsuura S, Inada N, Takaki A et al. Autism-associated gene expression in peripheral leucocytes commonly observed between subjects with autism and healthy women having autistic children. PLoS One 2011; 6: e24723.
44. Kurokawa K, Kuwano Y, Tominaga K, Kawai T, Katsuura S, Yamagishi N et al. Brief naturalistic stress induces an alternative splice variant of SMG-1 lacking exon 63 in peripheral leukocytes. Neurosci Lett 2010; 484: 128-132.